Weight Loss

Retatrutide

Triple-agonist research peptide studied for metabolic and body-composition endpoints.

Select Strength

$95

Final price — no added fees

Overview

Retatrutide is a synthetic triple receptor agonist targeting GLP-1, GIP, and glucagon pathways. It is one of the most studied next-generation metabolic research compounds, available here in six strengths for flexible study protocols.

Research Background

Investigational literature examines retatrutide's combined incretin and glucagon signaling for effects on appetite regulation, energy expenditure, and glycemic markers in preclinical and clinical research settings.

Specifications

Purity: ≥ 99% (HPLC verified)
Form: Lyophilized powder, sealed vial
Storage: Store at 2–8°C. Protect from light. Reconstituted: refrigerate and use within 30 days.
Strength: 10MG

Research use only. Not intended for human or animal consumption. Must be 18+.